title: New endoureteral double-J stent resists extrinsic ureteral compression.
abstract: The disadvantages of highly flexible endoureteral (double J) stents in the face of tumor-induced extrinsic ureteral compression are a consequence of insufficient cross-sectional stability, leading to stent compression and thus to hydronephrosis or pyonephrosis. The newly developed tumor stent, which is used in cases of tumor-induced ureteral compression, is available in sizes from 6F to 8F in diameter and 24 to 32 cm in length. The shaft consists of a combination of high-stability plastics that presents sufficient elasticity in length. Both ends are made of extremely elastic J parts, guaranteeing stable fixation. Compared with common double-J stents with the same outside diameter, the tumor stent possesses a comparable interior diameter and compared with available stents promises sufficient interior flow in the face of extrinsic diseases. The application can be undertaken using well-known endoscopic techniques, needs no special instrumentation, and entails no learning curve. To date, 49 stents were placed at our urologic departments without any problems, the latest stent remaining for 15 months. Tumor-induced compression or a higher rate of encrustation were not seen. All patients tolerated these stents well. In our opinion, the new stabilized endoureteral stent can be seen as a better solution than percutaneous nephrostomy or frequent stent changing to tumor-induced extrinsic ureteral compression.
authors.affiliation: Department of Urology and Pediatric Urology, Fulda Medical School, University of Marburg, Germany.
authors.forename: R W
authors.initials: RW
authors.lastname: Schlick
authors.forename: E M
authors.initials: EM
authors.lastname: Seidl
authors.forename: T
authors.initials: T
authors.lastname: Kalem
authors.forename: B
authors.initials: B
authors.lastname: Volkmer
authors.forename: K
authors.initials: K
authors.lastname: Planz
mesh_terms: D003251:Constriction, Pathologic / Q000517:prevention & control; D004867:Equipment Design; D006801:Humans; D010386:Pelvic Neoplasms / Q000150:complications; D012186:Retroperitoneal Neoplasms / Q000150:complications; D015607:Stents / Q000009:adverse effects; D016896:Treatment Outcome; D014513:Ureter; D014515:Ureteral Diseases / Q000517:prevention & control*